• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

VISTA,一种新型的小鼠 Ig 超家族配体,可负向调节 T 细胞反应。

VISTA, a novel mouse Ig superfamily ligand that negatively regulates T cell responses.

机构信息

Department of Microbiology and Immunology, Norris Cotton Cancer Center, Dartmouth Medical School, Lebanon, NH 03766, USA.

出版信息

J Exp Med. 2011 Mar 14;208(3):577-92. doi: 10.1084/jem.20100619. Epub 2011 Mar 7.

DOI:10.1084/jem.20100619
PMID:21383057
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3058578/
Abstract

The immunoglobulin (Ig) superfamily consists of many critical immune regulators, including the B7 family ligands and receptors. In this study, we identify a novel and structurally distinct Ig superfamily inhibitory ligand, whose extracellular domain bears homology to the B7 family ligand PD-L1. This molecule is designated V-domain Ig suppressor of T cell activation (VISTA). VISTA is primarily expressed on hematopoietic cells, and VISTA expression is highly regulated on myeloid antigen-presenting cells (APCs) and T cells. A soluble VISTA-Ig fusion protein or VISTA expression on APCs inhibits T cell proliferation and cytokine production in vitro. A VISTA-specific monoclonal antibody interferes with VISTA-induced suppression of T cell responses by VISTA-expressing APCs in vitro. Furthermore, anti-VISTA treatment exacerbates the development of the T cell-mediated autoimmune disease experimental autoimmune encephalomyelitis in mice. Finally, VISTA overexpression on tumor cells interferes with protective antitumor immunity in vivo in mice. These findings show that VISTA, a novel immunoregulatory molecule, has functional activities that are nonredundant with other Ig superfamily members and may play a role in the development of autoimmunity and immune surveillance in cancer.

摘要

免疫球蛋白(Ig)超家族包含许多关键的免疫调节剂,包括 B7 家族配体和受体。在这项研究中,我们鉴定了一种新型的、结构独特的 Ig 超家族抑制性配体,其细胞外结构域与 B7 家族配体 PD-L1 具有同源性。该分子被命名为 T 细胞活化的 V 结构域 Ig 抑制物(VISTA)。VISTA 主要在造血细胞上表达,其在髓系抗原呈递细胞(APC)和 T 细胞上的表达受到高度调控。VISTA-Ig 融合蛋白或 APC 上的 VISTA 表达可在体外抑制 T 细胞增殖和细胞因子产生。VISTA 特异性单克隆抗体可干扰 VISTA 表达的 APC 体外诱导的 T 细胞反应的抑制作用。此外,抗 VISTA 治疗可加重小鼠 T 细胞介导的自身免疫性疾病实验性自身免疫性脑脊髓炎的发展。最后,肿瘤细胞上的 VISTA 过表达可干扰小鼠体内保护性抗肿瘤免疫。这些发现表明,VISTA 作为一种新型的免疫调节分子,具有与其他 Ig 超家族成员不同的功能活性,可能在自身免疫和癌症免疫监视的发展中发挥作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f882/3058578/f2f5cb0a46fa/JEM_20100619_GS_Fig10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f882/3058578/e118efadd730/JEM_20100619_RGB_Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f882/3058578/45b4603329eb/JEM_20100619_RGB_Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f882/3058578/fe23d885e460/JEM_20100619_RGB_Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f882/3058578/5cec5c34f275/JEM_20100619_RGB_Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f882/3058578/fab8ab31dadf/JEM_20100619_RGB_Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f882/3058578/a127952f679a/JEM_20100619_LW_Fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f882/3058578/2cd6950c71c7/JEM_20100619_RGB_Fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f882/3058578/1c8a2ab316a1/JEM_20100619_RGB_Fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f882/3058578/1d1f1c5c474a/JEM_20100619_RGB_Fig9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f882/3058578/f2f5cb0a46fa/JEM_20100619_GS_Fig10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f882/3058578/e118efadd730/JEM_20100619_RGB_Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f882/3058578/45b4603329eb/JEM_20100619_RGB_Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f882/3058578/fe23d885e460/JEM_20100619_RGB_Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f882/3058578/5cec5c34f275/JEM_20100619_RGB_Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f882/3058578/fab8ab31dadf/JEM_20100619_RGB_Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f882/3058578/a127952f679a/JEM_20100619_LW_Fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f882/3058578/2cd6950c71c7/JEM_20100619_RGB_Fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f882/3058578/1c8a2ab316a1/JEM_20100619_RGB_Fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f882/3058578/1d1f1c5c474a/JEM_20100619_RGB_Fig9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f882/3058578/f2f5cb0a46fa/JEM_20100619_GS_Fig10.jpg

相似文献

1
VISTA, a novel mouse Ig superfamily ligand that negatively regulates T cell responses.VISTA,一种新型的小鼠 Ig 超家族配体,可负向调节 T 细胞反应。
J Exp Med. 2011 Mar 14;208(3):577-92. doi: 10.1084/jem.20100619. Epub 2011 Mar 7.
2
Targeting cell-surface VISTA expression on allospecific naïve T cells promotes tolerance.靶向同种特异性初始T细胞表面的VISTA表达可促进免疫耐受。
Blood. 2025 Apr 10;145(15):1687-1700. doi: 10.1182/blood.2024025884.
3
Macrophages suppress CD8 + T cell cytotoxic function in triple negative breast cancer via VISTA.巨噬细胞通过VISTA抑制三阴性乳腺癌中CD8 + T细胞的细胞毒性功能。
Br J Cancer. 2025 May 2. doi: 10.1038/s41416-025-03013-5.
4
VISTA functions as a protective immune checkpoint in indirect acute respiratory distress syndrome by modulating systemic and compartmentalized inflammation.VISTA通过调节全身和局部炎症,在间接急性呼吸窘迫综合征中发挥保护性免疫检查点的作用。
Front Immunol. 2025 Jul 1;16:1618135. doi: 10.3389/fimmu.2025.1618135. eCollection 2025.
5
VISTA is an immune checkpoint molecule for human T cells.VISTA 是一种人类 T 细胞的免疫检查点分子。
Cancer Res. 2014 Apr 1;74(7):1924-32. doi: 10.1158/0008-5472.CAN-13-1504.
6
VISTA Regulates the Development of Protective Antitumor Immunity.VISTA 调节抗肿瘤保护性免疫的发展。
Cancer Res. 2014 Apr 1;74(7):1933-44. doi: 10.1158/0008-5472.CAN-13-1506.
7
Oncolytic reovirus enhances the effect of CEA immunotherapy when combined with PD1-PDL1 inhibitor in a colorectal cancer model.在结直肠癌模型中,溶瘤呼肠孤病毒与PD1-PDL1抑制剂联合使用时可增强CEA免疫疗法的效果。
Immunotherapy. 2025 Apr;17(6):425-435. doi: 10.1080/1750743X.2025.2501926. Epub 2025 May 12.
8
CD6 regulates CD4 T follicular helper cell differentiation and humoral immunity during murine coronavirus infection.在小鼠冠状病毒感染期间,CD6调节CD4滤泡辅助性T细胞分化和体液免疫。
J Virol. 2025 Jan 31;99(1):e0186424. doi: 10.1128/jvi.01864-24. Epub 2024 Dec 16.
9
VISTA is a potential target for immunotherapy in B-cell acute lymphoblastic leukemia in children.VISTA是儿童B细胞急性淋巴细胞白血病免疫治疗的一个潜在靶点。
Sci Rep. 2025 Jul 3;15(1):23809. doi: 10.1038/s41598-025-08164-2.
10
INHBA promotes tumor growth and induces resistance to PD-L1 blockade by suppressing IFN-γ signaling.抑制素βA通过抑制γ干扰素信号通路促进肿瘤生长并诱导对程序性死亡受体配体1阻断的抗性。
Acta Pharmacol Sin. 2025 Feb;46(2):448-461. doi: 10.1038/s41401-024-01381-x. Epub 2024 Sep 2.

引用本文的文献

1
Macrophage-derived VISTA engages with LRIG1 and hinders gut epithelial repair in colitis.巨噬细胞衍生的VISTA与LRIG1相互作用并阻碍结肠炎中肠道上皮的修复。
Cell Mol Immunol. 2025 Aug 29. doi: 10.1038/s41423-025-01338-y.
2
Mechanisms of immune suppression in sepsis/shock: one investigator's/lab group's experience (SLB 2024 legacy award presentation).脓毒症/休克中免疫抑制的机制:一位研究者/实验室团队的经验(SLB 2024传承奖颁奖演讲)
J Leukoc Biol. 2025 Aug 5;117(8). doi: 10.1093/jleuko/qiaf108.
3
A Four Amino Acid Intracellular Motif of VISTA Blocks Growth Receptor Signaling in Cancer Cells to Induce Tumor Suppression.

本文引用的文献

1
The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans.B7家族成员B7-H6是人类中激活自然杀伤细胞受体NKp30的肿瘤细胞配体。
J Exp Med. 2009 Jul 6;206(7):1495-503. doi: 10.1084/jem.20090681. Epub 2009 Jun 15.
2
pGenTHREADER and pDomTHREADER: new methods for improved protein fold recognition and superfamily discrimination.pGenTHREADER和pDomTHREADER:用于改进蛋白质折叠识别和超家族区分的新方法。
Bioinformatics. 2009 Jul 15;25(14):1761-7. doi: 10.1093/bioinformatics/btp302. Epub 2009 May 7.
3
Using sequence similarity networks for visualization of relationships across diverse protein superfamilies.
VISTA的一个四氨基酸细胞内基序可阻断癌细胞中的生长受体信号传导,从而诱导肿瘤抑制。
Cancer Res. 2025 Jul 14. doi: 10.1158/0008-5472.CAN-24-4774.
4
VISTA is a potential target for immunotherapy in B-cell acute lymphoblastic leukemia in children.VISTA是儿童B细胞急性淋巴细胞白血病免疫治疗的一个潜在靶点。
Sci Rep. 2025 Jul 3;15(1):23809. doi: 10.1038/s41598-025-08164-2.
5
The role of VISTA engagement in limiting neutrophil-mediated inflammation.VISTA参与在限制中性粒细胞介导的炎症中的作用。
J Immunol. 2025 Jun 26. doi: 10.1093/jimmun/vkaf132.
6
Negative Immune Checkpoint Inhibitors.阴性免疫检查点抑制剂
Pharmaceutics. 2025 May 28;17(6):713. doi: 10.3390/pharmaceutics17060713.
7
Advances in molecular pathology and therapy of non-small cell lung cancer.非小细胞肺癌分子病理学与治疗的进展
Signal Transduct Target Ther. 2025 Jun 15;10(1):186. doi: 10.1038/s41392-025-02243-6.
8
Emerging Immunotherapy Targets in Early Drug Development.早期药物研发中新兴的免疫治疗靶点
Int J Mol Sci. 2025 Jun 4;26(11):5394. doi: 10.3390/ijms26115394.
9
Therapeutic targeting of tumour-associated macrophage receptors.肿瘤相关巨噬细胞受体的治疗靶向作用
Immunother Adv. 2025 Mar 11;5(1):ltaf009. doi: 10.1093/immadv/ltaf009. eCollection 2025.
10
Revealing the mechanisms and therapeutic potential of immune checkpoint proteins across diverse protein families.揭示不同蛋白质家族中免疫检查点蛋白的作用机制和治疗潜力。
Front Immunol. 2025 Apr 28;16:1499663. doi: 10.3389/fimmu.2025.1499663. eCollection 2025.
使用序列相似性网络可视化不同蛋白质超家族之间的关系。
PLoS One. 2009;4(2):e4345. doi: 10.1371/journal.pone.0004345. Epub 2009 Feb 3.
4
Crystal structure of the complex between programmed death-1 (PD-1) and its ligand PD-L2.程序性死亡蛋白1(PD-1)与其配体PD-L2复合物的晶体结构。
Proc Natl Acad Sci U S A. 2008 Jul 29;105(30):10483-8. doi: 10.1073/pnas.0804453105. Epub 2008 Jul 18.
5
Programmed death 1 ligand signaling regulates the generation of adaptive Foxp3+CD4+ regulatory T cells.程序性死亡1配体信号传导调节适应性Foxp3 + CD4 +调节性T细胞的产生。
Proc Natl Acad Sci U S A. 2008 Jul 8;105(27):9331-6. doi: 10.1073/pnas.0710441105. Epub 2008 Jul 2.
6
Inhibitory B7-family molecules in the tumour microenvironment.肿瘤微环境中的抑制性B7家族分子。
Nat Rev Immunol. 2008 Jun;8(6):467-77. doi: 10.1038/nri2326.
7
The PD-1/PD-L1 complex resembles the antigen-binding Fv domains of antibodies and T cell receptors.程序性死亡蛋白1(PD-1)/程序性死亡配体1(PD-L1)复合物类似于抗体和T细胞受体的抗原结合Fv结构域。
Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3011-6. doi: 10.1073/pnas.0712278105. Epub 2008 Feb 14.
8
PD-1 and its ligands in tolerance and immunity.PD-1及其配体在免疫耐受与免疫中的作用
Annu Rev Immunol. 2008;26:677-704. doi: 10.1146/annurev.immunol.26.021607.090331.
9
Ensembl 2008.Ensembl 2008。
Nucleic Acids Res. 2008 Jan;36(Database issue):D707-14. doi: 10.1093/nar/gkm988. Epub 2007 Nov 13.
10
Endothelial programmed death-1 ligand 1 (PD-L1) regulates CD8+ T-cell mediated injury in the heart.内皮程序性死亡-1配体1(PD-L1)调节心脏中CD8 + T细胞介导的损伤。
Circulation. 2007 Oct 30;116(18):2062-71. doi: 10.1161/CIRCULATIONAHA.107.709360. Epub 2007 Oct 15.